Depo-Provera® Treatment Does Not Abrogate Protection from Intravenous SIV Challenge in Female Macaques Immunized with an Attenuated AIDS Virus

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Genescá, Meritxell ^a,b   McChesney, Michael B ^b   Miller, Christopher J ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LIVE VACCINE; MEDROXYPROGESTERONE ACETATE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA;

ANIMAL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MACACA; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FLOW CYTOMETRY; HIV; LEUKOCYTES, MONONUCLEAR; MACACA; MEDROXYPROGESTERONE ACETATE; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VACCINES, ATTENUATED;

EID: 79952117239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009814     Document Type: Article

References (27)

1. Abel K, Compton L, Rourke T, Montefiori D, Lu D, et al. (2003) Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. J Virol 77: 3099-3118.
2. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, et al. (1997) Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 71: 1911-1921.
3. Stone M, Ma ZM, Genesca M, Fritts L, Blozois S, et al. (2009) Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus. Virology 392: 260-270.
4. Abel K, Rourke T, Lu D, Bost K, McChesney MB, et al. (2004) Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with Simian Immunodeficiency Virus mac239. J Infect Dis 190: 1697-1705.
5. Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L (2009) High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 23: 1255-1259.
6. Baeten JM, Lavreys L, Overbaugh J (2007) The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 45: 360-369.
7. Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, et al. (2009) HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial. AIDS 23: 1377-1382.
8. Bulterys M, Smith D, Chao A, Jaffe H (2007) Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS 21: 97-99.
9. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, et al. (1996) Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2: 1084-1089.
10. Wira CR, Fahey JV (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917.
11. Mauck C (2005) Overview of why hormones may be an issue. J Acquir Immune Defic Syndr 38 Suppl 1: S11-12.
12. Druckmann R, Druckmann MA (2005) Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 97: 389-396.
13. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, et al. (2006) Progestinbased contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 352: 169-177.
14. Mannel DN, Falk W, Yron I (1990) Inhibition of murine cytotoxic T cell responses by progesterone. Immunol Lett 26: 89-94.
15. Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11: 411-423.
16. Liang J, Sun L, Wang Q, Hou Y (2006) Progesterone regulates mouse dendritic cells differentiation and maturation. Int Immunopharmacol 6: 830-838.
17. Ghanem KG, Shah N, Klein RS, Mayer KH, Sobel JD, et al. (2005) Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 191: 358-366.
18. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG (2004) Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 189: 404-412.
19. Munoz LD, Serramia MJ, Fresno M, Munoz-Fernandez MA (2007) Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion. J Infect Dis 195: 1294-1302.
20. Asin SN, Heimberg AM, Eszterhas SK, Rollenhagen C, Howell AL (2008) Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells. AIDS Res Hum Retroviruses 24: 701-716.
21. Genesca M, Li J, Fritts L, Chohan P, Bost K, et al. (2007) Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. J Med Primatol 36: 266-275.
22. McChesney MB, Collins JR, Lu D, Lu X, Torten J, et al. (1998) Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-Tcell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 72: 10029-10035.
23. Genesca M, PJ S, JJ H, Li J, Bost K, et al. (2008) With minimal systemic T cell expansion, CD8+ T cells mediate protection from vaginal SIV challenge in rhesus macaques immunized with attenuated SHIV89.6. J Virology 82: 11181-11196.
24. Pantaleo G (2008) HIV-1 T-cell vaccines: evaluating the next step. Lancet Infect Dis 8: 82-83.
25. Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, et al. (2008) Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 180: 5439-5447.
26. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, et al. (2005) Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115: 1082-1091.
27. Pandrea I, Gaufin T, Brenchley JM, Gautam R, Monjure C, et al. (2008) Cutting edge: Experimentally induced immune activation in natural hosts of simian immunodeficiency virus induces significant increases in viral replication and CD4+ T cell depletion. J Immunol 181: 6687-6691.